Patrick M. Navolanic
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 7
- Melanoma and MAPK Pathways 6
- Protein Kinase Regulation and GTPase Signaling 5
- Cell death mechanisms and regulation 2
- Oncology 6
- Co-authors
- James Andrew McCubrey (17 shared papers)Linda S. Steelman (11 shared papers)Richard A. Franklin (10 shared papers)William L. Blalock (4 shared papers)J G Shelton (3 shared papers)Massimo Libra (14 shared papers)John Tayu Lee (3 shared papers)Fumin Chang (2 shared papers)
- Journals
- Leukemia (4 papers)International Journal of Oncology (3 papers)Cancer Biology & Therapy (2 papers)Cell Cycle (2 papers)BMC Cancer (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Patrick M. Navolanic
28 papers receiving 3.7k citations
Patrick M. Navolanic's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 429
- Oncology 584
- Molecular Biology 1.5k
- Hematology 158
- Hepatology 84
Countries citing papers authored by Patrick M. Navolanic
This map shows the geographic impact of Patrick M. Navolanic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Navolanic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Navolanic more than expected).
Fields of papers citing papers by Patrick M. Navolanic
This network shows the impact of papers produced by Patrick M. Navolanic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Navolanic. The network helps show where Patrick M. Navolanic may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick M. Navolanic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Hit paper breakdown → | 2003 | 1033 |
| 2 | 2003 | 606 | |
| 3 | 2006 | 572 | |
| 4 | Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). | 2003 | 346 |
| 5 | 2003 | 158 | |
| 6 | 2008 | 137 | |
| 7 | 2005 | 113 | |
| 8 | Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. | 2003 | 105 |
| 9 | 2005 | 88 | |
| 10 | Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. | 2001 | 78 |
| 11 | 2003 | 78 | |
| 12 | 2011 | 76 | |
| 13 | 2006 | 71 | |
| 14 | 2000 | 53 | |
| 15 | 2003 | 51 | |
| 16 | 2016 | 45 | |
| 17 | 2006 | 32 | |
| 18 | 2004 | 28 | |
| 19 | 2005 | 23 | |
| 20 | 2008 | 18 |
About Patrick M. Navolanic
Patrick M. Navolanic is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Cell Biology, having authored 28 papers that have together received 3.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Melanoma and MAPK Pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers), Microtubule and mitosis dynamics (2 papers), Peripheral Artery Disease Management (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Cancer Research (429 citations), Oncology (584 citations), Molecular Biology (1.5k citations), Hematology (158 citations) and Hepatology (84 citations). Patrick M. Navolanic has collaborated with scholars based in United States, Italy and France. Frequent co-authors include James Andrew McCubrey, Linda S. Steelman, Richard A. Franklin, William L. Blalock, J G Shelton, Massimo Libra, John Tayu Lee, Fumin Chang, Franca Stivala and María Clorinda Mazzarino. Their work appears in journals such as Leukemia, International Journal of Oncology, Cancer Biology & Therapy, Cell Cycle and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.